Scientific Highlights from Research Division Photon Science
(PSD)
Scientific Highlights
First light at Furka: The experiments can begin
The path to experiments that are unique in the world is now open.
Secret of Stradivarius violins revealed
As an international team of researchers discovered, the old Italian masters Stradivari and Guarneri relied on unexpected chemical additives in making violins.
Understanding the physics in new metals
Together with international colleagues, PSI researchers have now been able to make correlated metals more readily usable for applications in superconductivity, data processing, and quantum computers.
Synchrotron movies
Prof Philip Willmott, the author of the book 'Introduction to Synchrotron Radiation: techniques and applications' (second edition, John Wiley & Sons, Chichester, 2019. ISBN: 9781119280392), makes the scripts for the simulations and animations available to the public.
Tracking down unreported Coronavirus cases
The University Hospital of Zurich uses proteins made at PSI for Europe’s first large-scale serology study on coronavirus prevalence in Switzerland.
PSI: advancing in the fight against Covid-19
Crystal structure analysis, computer models, cell cultures – to pursue research on Sars-CoV-2, PSI is exploring many avenues. An overview.
Magnetic nanoworld
At PSI, researchers come across exotic phenomena such as frustrated magnets and nano-vortices, which may one day enable better data storage.
How catalysts age
Catalysts used in industry change their material structure over the years. Using a new method, PSI researchers have now studied this on the nanoscale.
Crystal structure of SARS-CoV-2 Orf9b in complex with human TOM70 suggests unusual virus-host interactions
In a study published in Nature Communications, researchers at the NHC Key Laboratory of Systems Biology of Pathogens in Beijing, China, in collaboration with the Paul Scherrer Institut characterize the interactions of SARS-CoV-2 orf9b and human TOM70 biochemically, and they determine the 2.2 Å crystal structure of the TOM70 cytosolic domain with a bound SARS-CoV-2 orf9b peptide.